ROIV (Roivant Sciences Ltd.) Stock Market Reviews

crown

search

Read and share opinions on ROIV (Roivant Sciences Ltd.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

ROIV

Roivant Sciences Ltd.

clarify Biotechnology

bookmark Healthcare

public United Kingdom

Sell Neutral Buy

Latest News

Will Roivant Sciences’ (ROIV) Slowing Revenue Growth Shape Its Long-Term Innovation Story?
Nov 11, 2025
Roivant Sciences Ltd (ROIV) Q2 2025 Earnings Call Highlights: Strong Financial Position and ...
Nov 10, 2025
Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Lags Revenue Estimates
Nov 10, 2025
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
Nov 10, 2025
Roivant Sciences (ROIV): Evaluating Valuation After Strong Share Price Momentum in Biotech
Oct 29, 2025
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
Oct 27, 2025
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
Oct 27, 2025
Wall Street Has a Mixed Opinion on Roivant Sciences Ltd (ROIV)
Oct 21, 2025
Roivant’s Brepocitinib Phase 3 Dermatomyositis Trial Hits Primary and All Key Secondary Endpoints
Oct 4, 2025
Why Analysts Are Rethinking Roivant Sciences After Strong Phase 3 Results and Analyst Upgrades
Oct 4, 2025
Are You Looking for a Top Momentum Pick? Why Roivant Sciences Ltd. (ROIV) is a Great Choice
Sep 23, 2025
Roivant Sciences (ROIV) Hits New All-Time High as Drug Candidate Clinical Trial Posts Impressive Results
Sep 18, 2025
Montes Archimedes Acquisition (ROIV) Surges 7.8%: Is This an Indication of Further Gains?
Sep 18, 2025
Roivant Flirts With A Profit-Taking Zone, Stoked By Promise In Autoimmune Disease
Sep 17, 2025

Reviews